A carregar...
Prevalence and Determinants of End of Life Chemotherapy Use in Patients with Metastatic Breast Cancer
BACKGROUND: Cessation of chemotherapy in the last few weeks of life could be an important quality of care benchmark. Proportion of metastatic breast cancer patients who receive end of life chemotherapy is not well described. We aimed to determine the prevalence and determinants of end of life chemot...
Na minha lista:
| Publicado no: | Breast J |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675818/ https://ncbi.nlm.nih.gov/pubmed/28845536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tbj.12905 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|